FDA Approved: FROVATRIPTAN SUCCINATE — Original Application (Glenmark Pharmaceuticals Inc., USA)

View source ↗

Summary

FDA approved Glenmark's frovatriptan succinate as an Original Application (ANDA) for the acute treatment of migraine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Frovatriptan succinate (FROVATRIPTAN SUCCINATE)

Snippet

ORIG AP for FROVATRIPTAN SUCCINATE (FROVATRIPTAN SUCCINATE)